Precision Cancer Test Validated for Clinical Usage July 20, 2016 A powerful next-generation genome-sequencing test developed at Weill Cornell Medicine can detect mutations that guide precision cancer treatment with over 95 percent accuracy.
We Are Weill Cornell Medicine: New Campaign Celebrates Accomplished, Collaborative Community July 18, 2016 People are the heart and soul of Weill Cornell Medicine, driving our efforts to advance healthcare and biomedical science and inspiring us in our endeavors every day. A new multimedia campaign, called We Are Weill Cornell Medicine, celebrates the people who make the institution special.